In focus
Latest feed
A Deeper Look at Assembly Biosciences' Latest Financial Journey
Palatin's Latest Quarter: Vyleesi Surges, Key Drug Trials Advance, and a Glimpse into the Future
Sana Biotechnology: A Deep Dive into a Speculative Biotech Bet
Veradermics Steps Onto the Public Stage: A Deep Dive into Their $200 Million IPO Bet
Latest headlines
